Join Annette Bowyer as She Explores Heparin-Induced Thrombocytopenia!
Sysmex Europe Haemostasis shared on LinkedIn:
”We are delighted to launch Season 2 of our haemostasis webinar series “Haemostasis and Beyond. Meet the Expert”!
Our first session will focus on an important topic:
Heparin-induced thrombocytopenia (HIT) – a severe complication in patients treated with heparins, including unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). HIT can result in serious thromboembolic events, often associated with considerable morbidity and mortality.
Join Annette Bowyer as she explores:
- What HIT is and how it develops
- Current approaches to diagnosis and management
- The essential role of the HISCL HIT IgG assay kit in supporting patient care
Save the date: 16.10.2025, 11:00 CEST
Link.
Do not miss the opening session of Season 2 – expand your knowledge, meet the experts, and stay at the forefront of haemostasis diagnostics.”

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
